• Drug Discovery
    • Heterobifunctionals
    • Covalency
  • QUAISAR Platform
    • Quantum Mechanics
    • Thermodynamics
    • Molecular Simulation
    • Supercomputing Infrastructure
  • About
    • Leadership Team
    • Roivant Sciences
    • Scientific Advisors
    • Open Science Fellows
    • Scientific Publications
  • Careers
    • Open Positions
  • Contact
Roivant Discovery Logo
  • Drug Discovery
    • Heterobifunctionals
    • Covalency
  • QUAISAR Platform
    • Quantum Mechanics
    • Thermodynamics
    • Molecular Simulation
    • Supercomputing Infrastructure
  • About
    • Leadership Team
    • Roivant Sciences
    • Scientific Advisors
    • Open Science Fellows
    • Scientific Publications
  • Careers
    • Open Positions
  • Contact
  About  Scientific Advisors

Scientific Advisors

The members of the Roivant Discovery scientific advisory board (SAB) are world-leading experts in quantum physics, computational drug development, parallel computing, biology and chemistry. Our SAB also includes clinicians whose insights into the needs of patients help guide the development of a new scientific paradigm and delivery of novel medicines for patients in need.

Share this:

  • Twitter
  • Facebook
  • Drug Discovery
    • Heterobifunctionals
    • Covalency
  • QUAISAR Platform
    • Quantum Mechanics
    • Thermodynamics
    • Molecular Simulation
    • Supercomputing Infrastructure
  • About
    • Leadership Team
    • Roivant Sciences
    • Scientific Advisors
    • Open Science Fellows
    • Scientific Publications
  • Careers
    • Open Positions
  • Contact
  • Timothy P. Heffernan Portrait

    Timothy P. Heffernan, Ph.D.

    Head of Oncology Research, Division of Therapeutics Discovery & Development; Executive Director, Translational Research to Advance Therapeutics and Innovation in Oncology (TRACTION) Platform, The University of Texas MD Anderson Cancer Center, Houston.

  • Sun Hur Portrait

    Sun Hur, Ph.D.

    Oscar M. Schloss Professor, Department of Biological Chemistry and Molecular Pharmacology, Department of Pediatrics, Harvard Medical School

  • Pasi Jänne Portrait

    Pasi A. Jänne, M.D., Ph.D.

    Thoracic medical oncologist at the Dana-Farber Cancer Institute; Professor at Harvard Medical School; Director of the Lowe Center for Thoracic Oncology; Director of the Belfer Center for Applied Cancer Science

Roivant Sciences
Open Science Fellows
Roivant Discovery Logo
  • Contact
  • Privacy Policy
  • Terms of Use

Follow:

  • Linkedin
  • Twitter
  • Youtube
© 2022 Roivant Sciences